KHIDI is an institution specializing in the planning·evaluation· management of domestic R&D projects related to healthcare.
We invest mainly in promising, next-generation technologies such as innovative new drugs, medical devices, and regenerative medicine and are focusing on supporting the development of medical technologies based on the 4th Industrial Revolution, such as big data and AI.

We provide the entire range of services from consultation, funding, and investment attraction at the Biohealth Innovation Start-up Center to support businesses throughout the entire process, ensuring the successful commercialization of great healthcare technologies and ideas. Our goal is to support global business expansion by strengthening Korea’s pharmaceutical industry and fostering the medical device industry through the Medical Device Industry Act.

KHIDI supports initiatives to protect the rights and interests of foreign patients, and promotes the convenience of using medical care in Korea so that patients can receive safe and high-quality medical and healthcare services.
Through intergovernmental cooperation, KHIDI enhances the international competitiveness of the nation's healthcare industry and contributes high added value to the industry through job creation.